Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Charles Daley

Concepts (471)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mycobacterium Infections, Nontuberculous
100
2026
339
18.090
 Why?
Mycobacterium avium-intracellulare Infection
29
2026
63
9.480
 Why?
Mycobacterium abscessus
43
2026
110
9.110
 Why?
Mycobacterium avium Complex
44
2026
87
8.540
 Why?
Nontuberculous Mycobacteria
54
2026
189
7.850
 Why?
Lung Diseases
47
2026
782
7.690
 Why?
Anti-Bacterial Agents
69
2026
1925
6.470
 Why?
Antitubercular Agents
39
2025
208
5.250
 Why?
Tuberculosis
33
2025
284
4.870
 Why?
Tuberculosis, Pulmonary
26
2025
127
4.330
 Why?
Tuberculosis, Multidrug-Resistant
14
2025
47
3.430
 Why?
Amikacin
19
2026
29
3.400
 Why?
Mycobacterium Infections
12
2019
55
3.150
 Why?
Mycobacterium
16
2026
101
2.910
 Why?
Mycobacterium kansasii
10
2020
14
2.830
 Why?
Bronchiectasis
19
2026
115
2.740
 Why?
Cystic Fibrosis
22
2025
1163
2.610
 Why?
Mycobacterium tuberculosis
28
2025
318
2.600
 Why?
Macrolides
15
2023
67
2.240
 Why?
Interferon-gamma Release Tests
7
2025
32
1.980
 Why?
Drug Resistance, Bacterial
21
2023
185
1.860
 Why?
Microbial Sensitivity Tests
29
2026
365
1.680
 Why?
Sputum
25
2020
302
1.510
 Why?
Disease Outbreaks
7
2025
419
1.390
 Why?
Humans
205
2026
145785
1.290
 Why?
Latent Tuberculosis
8
2017
70
1.190
 Why?
Pneumonia, Bacterial
6
2017
113
1.160
 Why?
Drug Therapy, Combination
22
2026
1043
1.120
 Why?
AIDS-Related Opportunistic Infections
4
2016
130
1.090
 Why?
Boron Compounds
2
2026
29
1.090
 Why?
Antibiotics, Antitubercular
9
2021
35
1.050
 Why?
Clofazimine
4
2021
15
1.050
 Why?
Rifampin
14
2024
79
1.040
 Why?
Ethambutol
11
2026
27
1.010
 Why?
Clarithromycin
14
2026
24
0.950
 Why?
Pneumonia
5
2023
636
0.940
 Why?
Tetracyclines
1
2025
16
0.920
 Why?
Patient Reported Outcome Measures
2
2026
498
0.830
 Why?
Treatment Outcome
35
2026
11794
0.830
 Why?
Oxazolidinones
3
2013
17
0.820
 Why?
Acetamides
3
2013
41
0.800
 Why?
HIV Infections
15
2022
3195
0.770
 Why?
Global Health
8
2018
403
0.770
 Why?
Fatigue
1
2025
366
0.760
 Why?
Aged
57
2026
26217
0.750
 Why?
Tuberculin Test
6
2016
36
0.720
 Why?
Equipment Contamination
2
2019
67
0.680
 Why?
Azithromycin
7
2026
101
0.680
 Why?
Middle Aged
64
2026
36309
0.670
 Why?
Professional Practice Gaps
1
2020
15
0.640
 Why?
Imipenem
7
2024
16
0.620
 Why?
beta-Lactams
3
2026
32
0.620
 Why?
Adult
57
2026
40882
0.600
 Why?
Disease Management
4
2021
653
0.600
 Why?
Female
82
2026
79045
0.590
 Why?
Male
82
2026
73012
0.580
 Why?
San Francisco
10
2014
60
0.550
 Why?
Practice Guidelines as Topic
9
2026
1582
0.550
 Why?
Molecular Epidemiology
4
2006
74
0.540
 Why?
Administration, Inhalation
7
2026
571
0.510
 Why?
Algorithms
1
2025
1851
0.500
 Why?
Health Care Sector
2
2013
26
0.480
 Why?
Linezolid
5
2026
25
0.480
 Why?
Recurrence
11
2025
1139
0.480
 Why?
Extensively Drug-Resistant Tuberculosis
2
2013
6
0.470
 Why?
beta-Lactamase Inhibitors
6
2026
9
0.470
 Why?
Drug Resistance, Multiple, Bacterial
4
2019
77
0.470
 Why?
Nebramycin
2
2025
2
0.460
 Why?
United States
32
2025
16126
0.460
 Why?
Phylogeny
5
2021
917
0.450
 Why?
Genome, Bacterial
5
2021
123
0.450
 Why?
Lung
16
2024
4116
0.450
 Why?
World Health Organization
3
2024
104
0.430
 Why?
Retrospective Studies
29
2025
17330
0.420
 Why?
Drug Synergism
4
2024
354
0.400
 Why?
Organ Transplantation
2
2024
253
0.400
 Why?
Communicable Disease Control
1
2014
86
0.390
 Why?
Sex Factors
1
2019
2110
0.380
 Why?
Serologic Tests
1
2012
54
0.370
 Why?
Quality of Life
8
2026
3211
0.360
 Why?
Professional Practice
1
2012
57
0.360
 Why?
Rifabutin
2
2012
7
0.350
 Why?
Opportunistic Infections
1
2011
47
0.340
 Why?
Pyrazinamide
4
2021
16
0.330
 Why?
Antibiotic Prophylaxis
1
2012
134
0.330
 Why?
Liposomes
2
2026
263
0.320
 Why?
Cefoxitin
4
2026
8
0.320
 Why?
Drug Administration Schedule
8
2025
782
0.310
 Why?
Occupational Health
1
2013
213
0.310
 Why?
Aged, 80 and over
15
2025
8347
0.300
 Why?
Occupational Exposure
1
2013
355
0.290
 Why?
Cross Infection
2
2025
260
0.280
 Why?
Disease Progression
8
2026
2865
0.280
 Why?
Diarylquinolines
3
2025
16
0.280
 Why?
Mass Screening
3
2016
1361
0.280
 Why?
Incidence
10
2019
2934
0.280
 Why?
Cardiac Surgical Procedures
3
2019
611
0.270
 Why?
Dose-Response Relationship, Drug
6
2026
2028
0.270
 Why?
Double-Blind Method
5
2026
2064
0.260
 Why?
Directly Observed Therapy
2
2005
16
0.260
 Why?
Antigens, Bacterial
5
2012
126
0.260
 Why?
Carcinoma, Squamous Cell
1
2012
641
0.260
 Why?
Europe
3
2025
421
0.260
 Why?
Cefuroxime
2
2024
5
0.260
 Why?
Prospective Studies
16
2025
8078
0.250
 Why?
Tuberculosis, Pleural
2
2003
7
0.250
 Why?
Health Personnel
3
2014
757
0.240
 Why?
Treatment Failure
5
2026
360
0.240
 Why?
Cephalosporins
2
2024
45
0.240
 Why?
Morbidity
2
2019
322
0.240
 Why?
Tomography, X-Ray Computed
9
2020
2770
0.240
 Why?
Suspensions
1
2026
28
0.240
 Why?
Genomics
4
2021
830
0.230
 Why?
Administration, Oral
4
2025
867
0.220
 Why?
Phage Therapy
1
2025
17
0.220
 Why?
ROC Curve
4
2020
618
0.220
 Why?
Antibodies, Monoclonal
1
2012
1505
0.220
 Why?
Diagnostic Tests, Routine
2
2019
107
0.220
 Why?
Oxazepines
2
2025
5
0.220
 Why?
Benzoxazoles
2
2025
20
0.220
 Why?
Peptidyl Transferases
2
2024
8
0.220
 Why?
Mutation
5
2019
4090
0.220
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2025
46
0.210
 Why?
Disease Transmission, Infectious
1
2005
69
0.210
 Why?
Water Microbiology
1
2005
85
0.210
 Why?
DNA Fingerprinting
1
2004
28
0.210
 Why?
Contact Tracing
1
2004
26
0.210
 Why?
Arizona
1
2024
80
0.210
 Why?
Boronic Acids
1
2024
36
0.200
 Why?
Alveolitis, Extrinsic Allergic
1
2005
93
0.200
 Why?
Research
2
2018
431
0.200
 Why?
DNA, Bacterial
3
2021
320
0.200
 Why?
Adolescent
19
2025
22577
0.200
 Why?
Self Administration
1
2004
122
0.200
 Why?
Risk Factors
9
2019
10919
0.200
 Why?
Medical Tourism
1
2023
9
0.200
 Why?
Mexico
1
2024
233
0.200
 Why?
Time Factors
8
2026
7134
0.190
 Why?
Colorado
5
2024
4556
0.190
 Why?
Biomedical Research
5
2020
719
0.190
 Why?
London
1
2023
46
0.190
 Why?
Biomarkers
3
2020
4302
0.190
 Why?
Leprostatic Agents
1
2022
6
0.190
 Why?
Stem Cell Transplantation
1
2024
189
0.190
 Why?
Clinical Trials as Topic
5
2026
1062
0.190
 Why?
Republic of Korea
6
2019
43
0.180
 Why?
Young Adult
12
2025
14254
0.180
 Why?
Forced Expiratory Volume
6
2025
450
0.180
 Why?
Pneumonectomy
2
2016
167
0.180
 Why?
Meningitis
1
2023
80
0.180
 Why?
Registries
5
2020
2410
0.180
 Why?
Spectinomycin
1
2021
2
0.180
 Why?
Isoniazid
4
2019
70
0.180
 Why?
Thorax
1
2022
51
0.170
 Why?
Lung Neoplasms
2
2012
2668
0.170
 Why?
Radiography, Thoracic
3
2017
172
0.170
 Why?
Psychometrics
1
2025
732
0.170
 Why?
Reproducibility of Results
3
2025
3418
0.170
 Why?
Comorbidity
4
2019
1662
0.170
 Why?
Cohort Studies
8
2020
6033
0.160
 Why?
Safety
1
2003
358
0.160
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2020
6
0.160
 Why?
Sensitivity and Specificity
5
2025
2000
0.160
 Why?
Cluster Analysis
4
2020
501
0.160
 Why?
Respiratory Therapy
1
2020
25
0.160
 Why?
Serine Proteases
1
2020
26
0.160
 Why?
Bacteriophages
1
2022
110
0.160
 Why?
Prevalence
4
2019
2875
0.150
 Why?
Child
13
2025
22740
0.150
 Why?
Area Under Curve
3
2020
332
0.150
 Why?
Nitroimidazoles
1
2019
16
0.150
 Why?
Mycobacterium fortuitum
1
2019
2
0.150
 Why?
Follow-Up Studies
5
2020
5428
0.150
 Why?
Oxazoles
1
2019
48
0.150
 Why?
Durable Medical Equipment
1
2019
5
0.150
 Why?
Genotyping Techniques
1
2019
71
0.150
 Why?
Bronchoscopy
1
2020
227
0.150
 Why?
Cost of Illness
1
2021
324
0.140
 Why?
Surveys and Questionnaires
2
2025
6085
0.140
 Why?
Genotype
6
2019
1857
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2021
261
0.140
 Why?
DNA Gyrase
1
2018
8
0.140
 Why?
Patient Selection
1
2003
739
0.140
 Why?
Azabicyclo Compounds
3
2024
7
0.140
 Why?
Aza Compounds
2
2010
12
0.140
 Why?
Respiratory System Agents
1
2018
22
0.140
 Why?
Internationality
1
2019
156
0.130
 Why?
Hospitals
1
2023
733
0.130
 Why?
Disease Models, Animal
3
2025
4568
0.130
 Why?
Tertiary Care Centers
1
2019
195
0.130
 Why?
Patient Compliance
3
2011
588
0.130
 Why?
Musculoskeletal Diseases
1
2019
91
0.130
 Why?
Tuberculosis Vaccines
2
2010
4
0.130
 Why?
Anti-HIV Agents
3
2016
912
0.130
 Why?
Hematopoietic Stem Cell Transplantation
1
2024
699
0.130
 Why?
alpha 1-Antitrypsin Deficiency
1
2018
61
0.130
 Why?
Pulmonary Medicine
1
2018
78
0.130
 Why?
Biological Specimen Banks
1
2018
118
0.130
 Why?
Salvage Therapy
1
2018
165
0.130
 Why?
Elephants
1
2017
7
0.130
 Why?
Interferon-gamma
4
2007
784
0.130
 Why?
Agammaglobulinemia
1
2017
36
0.130
 Why?
Fluoroquinolones
3
2018
44
0.130
 Why?
Databases, Genetic
1
2018
238
0.120
 Why?
Surgical Equipment
1
2016
8
0.120
 Why?
Quinolines
2
2010
190
0.120
 Why?
Kartagener Syndrome
1
2016
31
0.120
 Why?
Staphylococcal Infections
2
2018
393
0.120
 Why?
Prognosis
5
2020
4330
0.120
 Why?
Genes, Bacterial
1
2016
152
0.120
 Why?
Immunologic Deficiency Syndromes
1
2016
68
0.120
 Why?
Levofloxacin
1
2016
21
0.120
 Why?
Adrenal Cortex Hormones
1
2019
484
0.120
 Why?
Cough
3
2023
124
0.110
 Why?
Public Health
4
2016
574
0.110
 Why?
Gene Expression Regulation
2
2020
2601
0.110
 Why?
Surgical Wound Infection
1
2019
329
0.110
 Why?
Patient Outcome Assessment
1
2016
130
0.110
 Why?
Gene Expression Profiling
2
2020
1777
0.110
 Why?
Chronic Disease
3
2023
1812
0.110
 Why?
Drug Tolerance
1
2015
99
0.110
 Why?
Guidelines as Topic
1
2016
268
0.110
 Why?
Sequence Analysis, DNA
2
2014
778
0.100
 Why?
Drug Evaluation, Preclinical
2
2026
196
0.100
 Why?
Antiretroviral Therapy, Highly Active
2
2007
279
0.100
 Why?
DNA Transposable Elements
2
2006
124
0.100
 Why?
Genetic Variation
2
2021
977
0.100
 Why?
Peptidoglycan
2
2026
28
0.100
 Why?
beta-Lactamases
2
2026
53
0.100
 Why?
CD4 Lymphocyte Count
2
2004
280
0.100
 Why?
MicroRNAs
1
2020
686
0.100
 Why?
Anti-Inflammatory Agents
1
2017
478
0.100
 Why?
Computational Biology
1
2018
669
0.100
 Why?
Patient Acceptance of Health Care
2
2018
883
0.100
 Why?
Societies, Medical
4
2020
900
0.100
 Why?
Patient-Centered Care
1
2018
547
0.100
 Why?
Glucocorticoids
1
2017
532
0.090
 Why?
Contraindications
1
2012
90
0.090
 Why?
Gene Expression Regulation, Bacterial
1
2015
337
0.090
 Why?
Immunoenzyme Techniques
1
2012
200
0.090
 Why?
Models, Statistical
1
2016
672
0.090
 Why?
Glycolipids
1
2012
53
0.090
 Why?
Transcriptome
2
2015
1042
0.090
 Why?
Cytokines
2
2011
2069
0.090
 Why?
Antibodies, Bacterial
1
2012
147
0.090
 Why?
Randomized Controlled Trials as Topic
1
2018
1752
0.090
 Why?
Drug Resistance, Multiple
1
2011
25
0.090
 Why?
Chemical and Drug Induced Liver Injury
2
2003
138
0.080
 Why?
Immunoglobulin A
1
2012
214
0.080
 Why?
Drug Interactions
1
2012
405
0.080
 Why?
Pulmonary Disease, Chronic Obstructive
2
2018
920
0.080
 Why?
Debridement
1
2011
85
0.080
 Why?
Kaplan-Meier Estimate
3
2019
971
0.080
 Why?
Virulence
1
2011
278
0.080
 Why?
Metagenomics
2
2021
150
0.080
 Why?
Hospitals, General
2
2014
25
0.080
 Why?
Animals
8
2025
38106
0.080
 Why?
Respiratory Tract Infections
1
2014
396
0.080
 Why?
Case-Control Studies
3
2020
3634
0.080
 Why?
Hepatitis, Viral, Human
1
2009
21
0.080
 Why?
Netherlands
2
2012
84
0.070
 Why?
Mice
5
2025
18358
0.070
 Why?
Bacteriological Techniques
1
2009
66
0.070
 Why?
Confidence Intervals
2
2015
330
0.070
 Why?
Forkhead Transcription Factors
2
2007
209
0.070
 Why?
Interleukins
2
2007
248
0.070
 Why?
Clinical Decision-Making
2
2026
364
0.070
 Why?
Lung Transplantation
1
2012
332
0.070
 Why?
Early Diagnosis
1
2009
251
0.070
 Why?
Vitamins
1
2010
184
0.070
 Why?
Proportional Hazards Models
2
2019
1330
0.070
 Why?
Radiography
2
2008
853
0.070
 Why?
RNA, Ribosomal, 23S
2
2018
12
0.070
 Why?
Interleukin-9
1
2007
11
0.070
 Why?
Child, Preschool
4
2016
11868
0.070
 Why?
Logistic Models
3
2019
2139
0.070
 Why?
Hospitalization
1
2018
2461
0.070
 Why?
Survival Analysis
2
2016
1378
0.060
 Why?
Reagent Kits, Diagnostic
1
2007
33
0.060
 Why?
Interleukin-12 Subunit p40
1
2007
9
0.060
 Why?
Polysaccharides, Bacterial
1
2007
69
0.060
 Why?
Pneumonia, Pneumococcal
1
2007
47
0.060
 Why?
Congresses as Topic
2
2020
224
0.060
 Why?
Th1 Cells
1
2007
139
0.060
 Why?
Polymorphism, Single Nucleotide
3
2021
2181
0.060
 Why?
Vitamin D
1
2010
404
0.060
 Why?
Survivors
1
2010
523
0.060
 Why?
Liver Function Tests
2
2003
105
0.060
 Why?
Interleukin-8
1
2007
269
0.060
 Why?
Age Factors
3
2019
3346
0.060
 Why?
Japan
1
2026
149
0.060
 Why?
Monte Carlo Method
1
2026
148
0.060
 Why?
Keratosis
1
2025
16
0.060
 Why?
Regression Analysis
1
2008
1001
0.060
 Why?
Hydrotherapy
1
2005
7
0.060
 Why?
Penicillin-Binding Proteins
1
2024
2
0.050
 Why?
Bacterial Load
1
2025
67
0.050
 Why?
Immunosuppressive Agents
1
2009
838
0.050
 Why?
Microbial Viability
1
2025
83
0.050
 Why?
Coinfection
2
2018
143
0.050
 Why?
Antirheumatic Agents
1
2007
307
0.050
 Why?
Anti-Retroviral Agents
1
2007
251
0.050
 Why?
Whole Genome Sequencing
1
2025
178
0.050
 Why?
Cost-Benefit Analysis
2
2024
644
0.050
 Why?
Biopsy
2
2005
1082
0.050
 Why?
Mycobacterium xenopi
2
2014
2
0.050
 Why?
Respiratory Function Tests
2
2016
544
0.050
 Why?
Streptomycin
1
2003
18
0.050
 Why?
Delphi Technique
1
2026
333
0.050
 Why?
Molecular Docking Simulation
1
2024
119
0.050
 Why?
Carrier State
1
2004
78
0.050
 Why?
Influenza, Human
1
2009
624
0.050
 Why?
Dust
1
2023
92
0.050
 Why?
Multicenter Studies as Topic
1
2025
413
0.050
 Why?
Pseudomonas Infections
2
2016
231
0.050
 Why?
Staphylococcus aureus
2
2018
454
0.050
 Why?
Medicare
2
2019
904
0.050
 Why?
Substance Abuse, Intravenous
1
2004
127
0.050
 Why?
Tumor Necrosis Factor-alpha
1
2007
1217
0.050
 Why?
Homosexuality, Male
1
2004
231
0.050
 Why?
Predictive Value of Tests
2
2007
2123
0.050
 Why?
Databases, Factual
2
2019
1491
0.050
 Why?
Los Angeles
1
2002
73
0.040
 Why?
Transplant Recipients
1
2024
182
0.040
 Why?
Survival Rate
1
2007
2094
0.040
 Why?
Lactams
1
2021
28
0.040
 Why?
Drug Costs
1
2003
117
0.040
 Why?
Amoxicillin
1
2022
35
0.040
 Why?
Cross-Sectional Studies
3
2025
5925
0.040
 Why?
Phenotype
2
2021
3170
0.040
 Why?
Clone Cells
1
2021
263
0.040
 Why?
Bacterial Proteins
1
2007
968
0.040
 Why?
Carboxypeptidases
1
2020
12
0.040
 Why?
Real-Time Polymerase Chain Reaction
1
2021
337
0.040
 Why?
Water
1
2023
448
0.040
 Why?
Leukocyte Elastase
1
2020
75
0.040
 Why?
Gene Ontology
1
2020
54
0.040
 Why?
Ambulatory Care
1
2005
610
0.040
 Why?
Multivariate Analysis
1
2003
1547
0.040
 Why?
Chimera
1
2019
61
0.040
 Why?
Medication Adherence
1
2024
540
0.040
 Why?
United States Food and Drug Administration
1
2020
208
0.040
 Why?
Neutrophils
1
2025
1127
0.040
 Why?
Public Health Surveillance
1
2019
83
0.040
 Why?
Stem Cells
1
2023
630
0.040
 Why?
Meat
1
2019
64
0.040
 Why?
Cross-Over Studies
1
2021
610
0.040
 Why?
Mice, Inbred BALB C
1
2021
1261
0.040
 Why?
Molecular Diagnostic Techniques
1
2019
104
0.030
 Why?
Population Surveillance
1
2002
484
0.030
 Why?
Risk Assessment
2
2019
3752
0.030
 Why?
Ribosomal Proteins
1
2018
93
0.030
 Why?
Prosthesis-Related Infections
1
2019
98
0.030
 Why?
Insurance Claim Review
1
2018
83
0.030
 Why?
Symptom Assessment
1
2019
136
0.030
 Why?
Gene Expression
2
2016
1478
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
2
2011
849
0.030
 Why?
Gene Regulatory Networks
1
2020
318
0.030
 Why?
International Cooperation
1
2018
197
0.030
 Why?
Animals, Zoo
1
2017
15
0.030
 Why?
Drug Monitoring
2
2016
401
0.030
 Why?
Methyltransferases
1
2017
75
0.030
 Why?
Otitis
1
2016
9
0.030
 Why?
Pseudomonas
1
2016
30
0.030
 Why?
Delivery of Health Care
1
2023
948
0.030
 Why?
Drug Resistance, Microbial
1
2016
64
0.030
 Why?
Immunoglobulins
1
2017
163
0.030
 Why?
Micronesia
1
2016
8
0.030
 Why?
Mycobacterium chelonae
1
2016
8
0.030
 Why?
Spirometry
1
2016
233
0.030
 Why?
Host-Pathogen Interactions
1
2019
361
0.030
 Why?
Multiple Pulmonary Nodules
1
2016
23
0.030
 Why?
Vital Capacity
1
2016
292
0.030
 Why?
Injections, Intravenous
1
2016
197
0.030
 Why?
Body Temperature Regulation
1
2016
105
0.030
 Why?
Needs Assessment
1
2018
403
0.030
 Why?
Bronchi
1
2017
263
0.030
 Why?
Drug Combinations
1
2016
396
0.030
 Why?
Uganda
1
2015
90
0.030
 Why?
Leukocytes, Mononuclear
2
2007
574
0.030
 Why?
Rhinitis
1
2016
169
0.030
 Why?
Fibrosis
1
2017
561
0.030
 Why?
Gastroesophageal Reflux
1
2016
237
0.030
 Why?
Research Design
1
2020
1139
0.030
 Why?
Sinusitis
1
2016
227
0.030
 Why?
Insurance, Health
1
2016
311
0.030
 Why?
Sequence Homology, Nucleic Acid
1
2013
157
0.020
 Why?
RNA, Messenger
2
2015
2805
0.020
 Why?
False Positive Reactions
1
2014
123
0.020
 Why?
Consensus
1
2016
479
0.020
 Why?
Mycobacterium avium
1
2013
21
0.020
 Why?
DNA, Ribosomal Spacer
1
2012
7
0.020
 Why?
Mycolic Acids
1
2012
6
0.020
 Why?
Greece
1
2012
9
0.020
 Why?
Geography
1
2013
187
0.020
 Why?
Bacterial Typing Techniques
1
2012
40
0.020
 Why?
Iran
1
2012
44
0.020
 Why?
Self Report
1
2017
876
0.020
 Why?
Italy
1
2012
117
0.020
 Why?
Sweden
1
2012
115
0.020
 Why?
DNA-Directed RNA Polymerases
1
2012
62
0.020
 Why?
Cerebrospinal Fluid
1
2012
88
0.020
 Why?
Species Specificity
1
2013
546
0.020
 Why?
Developing Countries
2
2005
317
0.020
 Why?
Heat-Shock Proteins
1
2012
139
0.020
 Why?
Protein Array Analysis
1
2011
56
0.020
 Why?
Microspheres
1
2011
142
0.020
 Why?
Drug Discovery
1
2012
153
0.020
 Why?
Bone Marrow Cells
1
2012
322
0.020
 Why?
Demography
1
2011
282
0.020
 Why?
Adaptation, Physiological
1
2015
560
0.020
 Why?
Pseudomonas aeruginosa
1
2014
397
0.020
 Why?
In Vitro Techniques
1
2012
1049
0.020
 Why?
Evolution, Molecular
1
2014
494
0.020
 Why?
Body Mass Index
1
2019
2447
0.020
 Why?
Postoperative Care
1
2012
286
0.020
 Why?
RNA, Ribosomal, 16S
1
2012
508
0.020
 Why?
Referral and Consultation
1
2016
869
0.020
 Why?
Hepatitis, Chronic
1
2009
5
0.020
 Why?
Smoking
1
2016
1477
0.020
 Why?
Preoperative Care
1
2012
380
0.020
 Why?
Age Distribution
1
2010
404
0.020
 Why?
Sex Distribution
1
2010
388
0.020
 Why?
Pleural Diseases
1
2009
23
0.020
 Why?
Fatty Acids
1
2012
457
0.020
 Why?
Anxiety
1
2016
1122
0.020
 Why?
Transcription, Genetic
1
2015
1454
0.020
 Why?
Age of Onset
1
2010
557
0.020
 Why?
Vulnerable Populations
1
2009
176
0.020
 Why?
Molecular Sequence Data
1
2012
2883
0.020
 Why?
False Negative Reactions
1
2007
61
0.020
 Why?
Lymphatic Diseases
1
2007
21
0.020
 Why?
Urinalysis
1
2007
83
0.020
 Why?
Continuity of Patient Care
1
2009
297
0.020
 Why?
Depression
1
2016
1559
0.020
 Why?
Bone Diseases
1
2007
61
0.010
 Why?
Forced Expiratory Flow Rates
1
2006
10
0.010
 Why?
Clinical Laboratory Techniques
1
2007
96
0.010
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2010
373
0.010
 Why?
Longitudinal Studies
1
2014
2968
0.010
 Why?
Africa
1
2006
119
0.010
 Why?
Lung Diseases, Interstitial
1
2012
664
0.010
 Why?
Infection Control
1
2007
173
0.010
 Why?
Skin Diseases
1
2007
152
0.010
 Why?
C-Reactive Protein
1
2007
423
0.010
 Why?
Asthma
1
2016
1797
0.010
 Why?
India
1
2005
213
0.010
 Why?
Up-Regulation
1
2007
848
0.010
 Why?
Virus Latency
1
2005
90
0.010
 Why?
Anti-Infective Agents
1
2007
232
0.010
 Why?
Dendritic Cells
1
2007
501
0.010
 Why?
Quality of Health Care
1
2009
693
0.010
 Why?
Wounds and Injuries
1
2012
963
0.010
 Why?
Cost Savings
1
2004
86
0.010
 Why?
Diagnostic Techniques, Respiratory System
1
2003
5
0.010
 Why?
Pleura
1
2003
28
0.010
 Why?
HIV Seronegativity
1
2003
29
0.010
 Why?
Costs and Cost Analysis
1
2004
221
0.010
 Why?
Pleural Effusion
1
2003
59
0.010
 Why?
HIV Seropositivity
1
2003
119
0.010
 Why?
Severity of Illness Index
1
2010
2933
0.010
 Why?
Chi-Square Distribution
1
2003
528
0.010
 Why?
Infant
1
2016
10091
0.010
 Why?
Clinical Protocols
1
2003
280
0.010
 Why?
Mice, Inbred C57BL
1
2012
5995
0.010
 Why?
Data Interpretation, Statistical
1
2003
368
0.010
 Why?
Health Policy
1
2004
400
0.010
 Why?
Models, Theoretical
1
2004
560
0.010
 Why?
Hypertension, Pulmonary
1
2012
1957
0.010
 Why?
Rural Population
1
2005
661
0.010
 Why?
Liver
1
2002
1899
0.010
 Why?
Daley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (471) concept(s)
_
Co-Authors Expand Description
See all (33) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)